Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells
Alves Rico, Samara R, Abbasi, Azhar Z, Ribeiro, Geise, Ahmed, Taksim, Wu, Xiao Yu, de Oliveira Silva, Denise
Published in Nanoscale (14.08.2017)
Published in Nanoscale (14.08.2017)
Get full text
Journal Article
A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties
Alves, Samara R., Santos, Rodrigo L.S.R., Fornaciari, Bárbara, Colquhoun, Alison, de Oliveira Silva, Denise
Published in Journal of inorganic biochemistry (01.12.2021)
Published in Journal of inorganic biochemistry (01.12.2021)
Get full text
Journal Article
Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells
Rehman, Hanif-Ur, Fornaciari, Bárbara, Alves, Samara R., Colquhoun, Alison, de Oliveira Silva, Denise
Published in Journal of microencapsulation (03.10.2023)
Published in Journal of microencapsulation (03.10.2023)
Get full text
Journal Article
Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cellsElectronic supplementary information (ESI) available: Cell uptake fluorescence microscopy images and CSLM of SPLNs in EMT6, MDA-MB-231 and DU145 cancer cell lines. See DOI: 10.1039/c7nr01582h
Alves Rico, Samara R, Abbasi, Azhar Z, Ribeiro, Geise, Ahmed, Taksim, Wu, Xiao Yu, de Oliveira Silva, Denise
Year of Publication 03.08.2017
Year of Publication 03.08.2017
Get full text
Journal Article